Under the brand name Zepbound , tirzepatide is FDA-approved for chronic weight management in adults with obesity (BMI 30 or higher) or overweight (BMI 27 or higher) who also have at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol
Antes de considerar la semaglutida, consulte con su mdico
Ro (Roman Health) operates as subscription telehealth: an intake, a virtual evaluation by a licensed clinician and, if eligible, a prescription
Primary conversion table Several important notes about this chart
Additionally, tirzepatide may delay gastric emptying, potentially reducing the absorption of oral medications including oral contraceptives
This muscle loss reduces metabolic rate, impairs function, and contributes to weight regain when medication stops